NET LOSS PER SHARE (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2024

Dec. 31, 2023

The following table sets forth the computation of the basic and diluted net loss per share (in thousands except share and per share data):


	For the Three Months Ended June 30,						For the Six Months Ended June 30,
	2024			2023			2024			2023
Numerator:
Net loss	$	(5,219	)	$	(3,435	)	$	(8,985	)	$	(9,707	)
Denominator:
Weighted-average ordinary shares outstanding used to compute net loss per share, basic and diluted		9,455,751			970,402			9,235,006			970,297
Net loss per share, basic and diluted:	$	(0.55	)	$	(3.54	)	$	(0.97	)	$	(10.00	)

The following table sets forth the computation of the basic and diluted net loss per share (in thousands except share and per share data):

	2023			2022
	Year ended December 31,
	2023			2022
Numerator:
Net loss	$	(11,264	)	$	(14,407	)
Denominator:
Weighted-average shares of common stock outstanding used to compute net loss per share, basic and diluted		3,302,818			655,665
Net loss per share, basic and diluted:	$	(3.41	)	$	(21.97	)

	2023		2022
	Year Ended December 31,
	2023		2022
Series A-1 redeemable convertible preferred stock		-		114,194
Series A-2 redeemable convertible preferred stock		-		19,411
Series A-3 redeemable convertible preferred stock		-		12,045
Series A-4 redeemable convertible preferred stock		—		-
Series A-5 redeemable convertible preferred stock		—		-
Series A-6 redeemable convertible preferred stock		—		-
Series B-1 redeemable convertible preferred stock		-		3,662
Series B-2 redeemable convertible preferred stock		-		220,021
Series C-1 redeemable convertible preferred stock		-		53,393
Series C-2 redeemable convertible preferred stock		-		41,595
Warrants to purchase redeemable convertible preferred stock		94,988		94,988
Stock options, issued and outstanding		284,437		179,107
Total		379,425		738,416

Notable Labs, Ltd. S-1/A